Respiri

Respiri develops a mobile health device and application that allows asthma patients to record and analyze their breathing. Read more

Marjan Mikel's photo - CEO of Respiri

CEO

Marjan Mikel

CEO Approval Rating

85/100

Founded:

1987

Status:

PublicIndependent CompanyAustralian Securities ExchangeRSH

RESPIRI TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Vitalograph is Respiri's top competitor. Vitalograph is a Private company that was founded in Lenexa, Kansas in 1963. Vitalograph operates in the Health Care Equipment industry. Vitalograph has 197 more employees vs. Respiri.

Spirosure has been one of Respiri's top competitors. Spirosure is headquartered in Pleasanton, California, and was founded in 2011. Spirosure is in the Health Care Services field. Spirosure generates 207% the revenue of Respiri.

Adherium is perceived as one of Respiri's biggest rivals. Adherium was founded in 2001 in Auckland, Auckland Region. Adherium competes in the Health Care Equipment field. Adherium generates $799.8K more revenue than Respiri.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Thorasys a competitor of Respiri?

Respiri Quarterly and Annual Revenue

Coming soon for Respiri!

Annual Revenue

$ < 1M

Respiri's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 8.3M.

Respiri Acquisitions

No recent acquisitions found related to Respiri

Respiri Funding History

Since Respiri was founded in 1987, it has participated in 5 rounds of funding. In total Respiri has raised $12.3M. Respiri's last funding round was on Mar 2020 for a total of $2.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Mar 2020
$2M
-
Private Placement
Jul 2019
$3.4M
-
Private Placement
Feb 2019
$724.4K
-
Private Placement
Dec 2018
$3.2M
-
Private Placement
Apr 2018
$3M
-

Since Respiri was founded in 1987, it has participated in 5 rounds of funding. In total Respiri has raised $12.3M. Respiri's last funding round was on Mar 2020 for a total of $2.0M

Respiri Investments

No recent investments found related to Respiri

Respiri News

March 23, 2021Australian Financial Review

Respiri Health scores FDA tick after 21 years of toil

Respiri Health CEO Marjan Mikel says the company now has a viable business model, after two decades o... See more »
March 23, 2021Stockhead

Watershed moment as Respiri's wheeze-detecting device approved for OTC sale in USA

Special Report: Respiri (ASX:RSH) has just achieved a huge corporate milestone: its wheeze-detecting ... See more »
March 11, 2021Stockhead

Asthma costs Australia $28 billion a year. Respiri wants to change that.

Special Report: Asthma is the fourth most-prevalent non-communicable disease in the world, killing an... See more »
February 8, 2021Stockhead

Pharmacists to begin recommending Respiri's wheezo asthma management device

Respiri (ASX:RSH) is taking a big step forward with an agreement for its Pharmacy Catalyst members to... See more »
December 18, 2020Stockhead

Respiri rolls out wheezo device distribution with Pharmacy 4 Less group

Special Report: Respiratory health company Respiri has entered into a sales and marketing partnership... See more »
December 9, 2020Stockhead

Respiri reasserts full-year revenue guidance after locking in key product order, shares climb

Special Report: Respiri's deal with Cipla will allow it to boost distribution of its wheezo asthma ma... See more »
November 3, 2020Stockhead

Respiri details 'exceptional' cost savings to wheezo production

Special Report: Respiri Limited's (ASX:RSH) expects its gross product margins for its wheezos to be 3... See more »

Respiri Press Releases

Respiri Videos

May 8, 2019Respiri Vimeo Channel

"Michael Clarke for Respiri" on VIMEO

Michael Clarke is Respiri's first brand ambassador. Hear from the former Australian Cricket Captain o... See more »
February 17, 2019Respiri Vimeo Channel

"Introducing wheezo, your asthma friend" on VIMEO

Cast: Respiri Ltd... See more »
November 20, 2018Respiri Vimeo Channel

"Respiri, customer driven product development" on VIMEO

CXO, Wani Wall talks about the Respiri mission and introduces us to severe asthma sufferer, James Car... See more »
November 12, 2018Respiri Vimeo Channel

"RESPIRI PRODUCT DEVELOPMENT UPDATE NOVEMBER 18" on VIMEO

Engineering and commercialisation partners, Evan Davey of Two Bulls and Jefferson Harcourt of Grey In... See more »
October 18, 2018Respiri Vimeo Channel

"RESPIRI OCTOBER 2018 UPDATE" on VIMEO

Professor Bruce Thompson, Respiri's Medical & Scientific Advisory Board Australian Chair and Product ... See more »

Social Media

Respiri Headquarters

10/446 Collins Street Level 29, South Tower

Melbourne, Victoria3000

61-3-9653-9160

Driving Directions »

Trending Companies

Respiri Summary

ABOUT

Overview

Respiri develops a mobile health device and application that allows asthma patients to record and analyze their breathing. Respiri was founded in 1987. Respiri's headquarters is located in Melbourne, Victoria, AU 3000. It has raised 12.3M in 5 rounds....

CEO

Respiri's CEO, Marjan Mikel, currently has an approval rating of 85%. Respiri's primary competitors are Vitalograph, Spirosure & Adherium.

Website

respiri.co

Frequently Asked Questions about Respiri

  1. When was Respiri founded?

    Respiri was founded in 1987
  2. Who is Respiri's CEO?

    Respiri's CEO is Marjan Mikel
  3. How much revenue does Respiri generate?

    Respiri generates $ < 1M in revenue
  4. How much funding does Respiri have?

    Respiri has historically raised $12.3M in funding
  1. Where is Respiri's headquarters?

    Respiri's headquarters is in Melbourne Victoria, AU
  2. How many employees does Respiri have?

    Respiri has 3 employees
  3. What sector does Respiri operate in?

    Respiri is in Health Care Equipment
  4. Who are Respiri's competitors?

    Respiri's top competitors are Vitalograph, Spirosure, Adherium